There were 1,917 press releases posted in the last 24 hours and 426,629 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
KI-Technologie von Evaxion identifiziert in klinischer Phase-I-Studie zu EVX-01 mit einem längeren progressionsfreien Überleben von Melanompatienten assoziierte Krebsimpfstoffziele

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image